3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
55
Ovarian Neoplasms
39
Carcinoma, Hepatocellular
39
Neoplasms
25
Fallopian Tube Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Endometrial Neoplasms
14
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Colonic Neoplasms
10
Neoplasm Metastasis
9
Lung Neoplasms
8
Liver Neoplasms
8
Uterine Cervical Neoplasms
7
Stomach Neoplasms
6
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms, Nerve Tissue
3
Gastrointestinal Neoplasms
3
Interventions
Rituximab
9
venetoclax
7
ibrutinib
7
Cyclophosphamide
7
Mycophenolic Acid
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
ixazomib
2
fludarabine
2
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Etoposide
2
Cyclosporins
2
Calcium Dobesilate
2
CT-P10
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
brexucabtagene autoleucel
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Bevacizumab
×
90 days
×
Clear all
No trials found.